10 research outputs found
Sirolimus and everolimus clearance in maintenance kidney and liver transplant recipients: Diagnostic efficiency of the concentration/dose ratio for the prediction of trough steady-state concentrations
Capacitação e intervenções de técnicos de farmácia na dispensação de medicamentos em Atenção Primária à Saúde
A contribuição do farmacêutico para a promoção do acesso e uso racional de medicamentos essenciais no SUS
Prevention of Nosocomial Infection in the Neurosciences Intensive Care Unit: Remember the Basics
Improving Head and Neck Microvascular Reconstructive Care with a Novel Perioperative Checklist
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
As pharmaceutical expenditure continues to rise, third-party payers in most high-income countries have increasingly shifted the burden of payment for prescription drugs to patients. A large body of literature has examined the relationship between prescription charges and outcomes such as expenditure, use, and health, but few reviews explicitly link cost sharing for prescription drugs to efficiency and equity. This article reviews 173 studies from 15 high-income countries and discusses their implications for important issues sometimes ignored in the literature; in particular, the extent to which prescription charges contain health care costs and enhance efficiency without lowering equity of access to care